Scarica l'app Stockscreener
145.56
4.20%
5.87
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AXSM Giù?
Forum
Previsione
Precedente Chiudi:
$139.69
Aprire:
$139.53
Volume 24 ore:
876.40K
Relative Volume:
1.64
Capitalizzazione di mercato:
$7.04B
Reddito:
$338.46M
Utile/perdita netta:
$-310.96M
Rapporto P/E:
-22.29
EPS:
-6.53
Flusso di cassa netto:
$-132.82M
1 W Prestazione:
+5.63%
1M Prestazione:
+13.77%
6M Prestazione:
+35.37%
1 anno Prestazione:
+56.23%
Intervallo 1D:
$138.90
$146.68
Intervallo di 1 settimana:
$136.00
$146.68
Portata 52W:
$75.56
$146.68
Axsome Therapeutics Inc Stock (AXSM) Company Profile
Nome
Axsome Therapeutics Inc
Settore
Industria
Telefono
(212) 332-3241
Indirizzo
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Confronta AXSM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AXSM
Axsome Therapeutics Inc
|
145.56 | 7.04B | 338.46M | -310.96M | -132.82M | -6.53 |
|
ARGX
Argen X Se Adr
|
929.61 | 55.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.02 | 110.91B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
197.40 | 41.21B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
376.63 | 40.48B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
704.31 | 72.89B | 14.25B | 4.58B | 3.88B | 41.77 |
Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-01 | Iniziato | B. Riley Securities | Buy |
| 2025-09-03 | Ripresa | Wells Fargo | Overweight |
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-06-03 | Iniziato | Oppenheimer | Outperform |
| 2025-04-07 | Iniziato | Jefferies | Buy |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-12-31 | Reiterato | Mizuho | Outperform |
| 2024-09-03 | Iniziato | Wells Fargo | Overweight |
| 2024-08-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-07-22 | Iniziato | Needham | Buy |
| 2024-04-29 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-03-19 | Iniziato | Robert W. Baird | Outperform |
| 2024-02-06 | Iniziato | UBS | Buy |
| 2024-01-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-12-13 | Iniziato | Citigroup | Buy |
| 2023-08-08 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-01-05 | Iniziato | Piper Sandler | Neutral |
| 2022-11-01 | Iniziato | Loop Capital | Buy |
| 2022-09-07 | Ripresa | Mizuho | Buy |
| 2021-08-10 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-10 | Iniziato | Berenberg | Buy |
| 2021-01-08 | Iniziato | Jefferies | Buy |
| 2020-12-16 | Iniziato | Mizuho | Buy |
| 2020-09-29 | Iniziato | BofA Securities | Underperform |
| 2020-09-10 | Iniziato | Morgan Stanley | Overweight |
| 2020-04-28 | Reiterato | H.C. Wainwright | Buy |
| 2020-04-14 | Iniziato | Cowen | Outperform |
| 2019-12-30 | Reiterato | H.C. Wainwright | Buy |
| 2019-12-17 | Reiterato | H.C. Wainwright | Buy |
| 2019-12-16 | Reiterato | Guggenheim | Buy |
| 2019-10-16 | Iniziato | Guggenheim | Buy |
| 2019-09-18 | Iniziato | William Blair | Outperform |
| 2019-05-28 | Iniziato | SunTrust | Buy |
| 2019-05-23 | Reiterato | H.C. Wainwright | Buy |
| 2019-04-08 | Iniziato | SVB Leerink | Outperform |
| 2019-03-15 | Reiterato | H.C. Wainwright | Buy |
| 2016-10-03 | Ripresa | Brean Capital | Buy |
| 2015-12-15 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-12-14 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Axsome Therapeutics Inc Borsa (AXSM) Ultime notizie
Axsome Therapeutics stock hits all-time high at 144.19 USD - Investing.com India
Axsome Therapeutics stock hits all-time high at 144.19 USD By Investing.com - Investing.com Australia
Will Axsome Therapeutics Inc. stock go up soonJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - newser.com
Envestnet Asset Management Inc. Grows Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Bank of New York Mellon Corp Has $21.26 Million Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
How Axsome Therapeutics Inc. stock compares to industry benchmarksProfit Target & Fast Gaining Stock Strategy Reports - newser.com
Historical volatility pattern of Axsome Therapeutics Inc. visualizedWeekly Trend Report & Smart Swing Trading Alerts - newser.com
How Axsome Therapeutics Inc. stock performs in rate cut cyclesPortfolio Risk Summary & Technical Pattern Based Buy Signals - newser.com
Axsome Therapeutics, Inc. $AXSM Shares Purchased by Los Angeles Capital Management LLC - MarketBeat
Candriam S.C.A. Trims Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics Inc. stock momentum explainedEarnings Risk Report & Safe Entry Zone Identification - newser.com
(AXSM) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Tools to assess Axsome Therapeutics Inc.’s risk profileTrade Volume Summary & Daily Stock Trend Watchlist - newser.com
What Wall Street predicts for Axsome Therapeutics Inc. stock priceGap Up & Free Technical Confirmation Trade Alerts - newser.com
Can machine learning forecast Axsome Therapeutics Inc. recoveryJuly 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - newser.com
How rising interest rates impact Axsome Therapeutics Inc. stock2025 Sector Review & Community Shared Stock Ideas - newser.com
Market reaction to Axsome Therapeutics Inc.’s recent newsInsider Selling & Low Risk High Win Rate Stock Picks - newser.com
Axsome Therapeutics Inc. recovery potential after sell offJuly 2025 Drop Watch & Community Shared Stock Ideas - newser.com
Why analysts recommend Axsome Therapeutics Inc. (19X) stock2025 Key Lessons & Daily Price Action Insights - Fundação Cultural do Pará
How Axsome Therapeutics Inc. (19X) stock reacts to Fed tighteningVolume Spike & Community Trade Idea Sharing - newser.com
Campbell & CO Investment Adviser LLC Purchases New Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Will Axsome Therapeutics Inc. stock sustain high P E ratios2025 Investor Takeaways & Daily Entry Point Trade Alerts - newser.com
How Axsome Therapeutics Inc. (19X) stock trades pre earningsM&A Rumor & Verified Swing Trading Watchlists - newser.com
Axsome Therapeutics (NASDAQ:AXSM) Hits New 12-Month HighWhat's Next? - MarketBeat
What candlestick patterns are forming on Axsome Therapeutics Inc.Gold Moves & Free AI Powered Buy and Sell Recommendations - newser.com
Avenue Therapeutics Sells Baergic Bio to Axsome - TipRanks
RBC Capital Sticks to Their Buy Rating for Axsome Therapeutics (AXSM) - The Globe and Mail
Claim your share of the $7.75M Axsome Therapeutics securities class action settlement - Claim Depot
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Is Axsome Therapeutics Inc. stock a buy on dipsJuly 2025 Fed Impact & Real-Time Market Trend Scan - newser.com
Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Axsome Therapeutics, Inc. Common StockAXSM - Markets Financial Content
Axsome Therapeutics acquires Baergic Bio from Avenue Therapeutics - MSN
2 Monster Stocks in the Making - Nasdaq
Connor Clark & Lunn Investment Management Ltd. Increases Stock Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Can Axsome Therapeutics Inc. stock continue upward trendJuly 2025 Retail & Advanced Technical Signal Analysis - newser.com
Why hedge funds are buying Axsome Therapeutics Inc. stockJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - newser.com
Axsome Therapeutics Inc. stock trend forecastJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - newser.com
Is Axsome Therapeutics Inc. forming a reversal pattern2025 Technical Overview & Real-Time Market Sentiment Alerts - newser.com
Axsome Therapeutics Eyes Baergic Bio: Is This the Next Big CNS Breakthrough? - Smartkarma
Axsome Therapeutics Inc Azioni (AXSM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.99%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):